High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus

Journal of Applied Physiology

Volumn 100, Issue 1, 2006, Pages 150-156

  Ceylan Isik, Asli F ^a   Wu, Shan ^a   Li, Qun ^a   Li, Shi Yan ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Advanced glycation end product; Contraction; Diabetes; Ventricular myocyte

Indexed keywords

BENFOTIAMINE; CALCIUM ION; CARBONIC ACID; STREPTOZOCIN; THIAMINE DERIVATIVE; BENPHOTHIAMINE; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; THIAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ELECTROSTIMULATION; GLYCATION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; LIPOPHILICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; EXPERIMENTAL DIABETES MELLITUS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; MUSCLE CELL; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART VENTRICLES; MALE; MICE; MUSCLE CELLS; MYOCARDIAL CONTRACTION; STREPTOZOCIN; THIAMINE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33644827653     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00988.2005     Document Type: Article

References (29)

1. Aberle NS, Burd L, Zhao BH, and Ren J. Acetaldehyde-induced cardiac contractile dysfunction may be alleviated by vitamin B1 but not by vitamins B6 or B12. Alcohol Alcohol 39: 450-454, 2004.
2. Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, and Thornalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52: 2110-2120, 2003.
3. Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, and Thornalley PJ. High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia 47: 2235-2246, 2004.
4. Beltramo E, Berrone E, Buttiglieri S, and Porta M. Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose. Diabetes Metab Res Rev 20: 330-336, 2004.
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
6. Chattou S, Diacono J, and Feuvray D. Decrease in sodium-calcium exchange and calcium currents in diabetic rat ventricular myocytes. Acta Physiol Scand 166: 137-144, 1999.
7. Depre C, Young ME, Ying J, Ahuja HS, Han Q, Garza N, Davies PJ, and Taegtmeyer H. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 32: 985-996, 2000.
8. Duan J, Zhang HY, Adkins SD, Ren BH, Norby FL, Zhang X, Benoit JN, Epstein PN, and Ren J. Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA. Am J Physiol Endocrinol Metab 284: E366-E376, 2003.
9. Gaynes BI and Watkins JB III. Carbon tetrachloride and the sorbitol pathway in the diabetic mouse. Comp Biochem Physiol B 94: 213-217, 1989.
10. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, and Brownlee M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9: 294-299, 2003.
11. Hintz KK, Relling DP, Saari JT, Borgerding AJ, Duan J, Ren BH, Kato K, Epstein PN, and Ren J. Cardiac overexpression of alcohol dehydrogenase exacerbates cardiac contractile dysfunction, lipid peroxidation, and protein damage after chronic ethanol ingestion. Alcohol Clin Exp Res 27: 1090-1098, 2003.
12. 2+] and pH in rat skinned cardiac myocytes. Am J Physiol Heart Circ Physiol 269: H1656-H1663, 1995.
13. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, and Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814, 1997.
14. Li S, Culver B, and Ren J. Benefit and risk of exercise on myocardial function in diabetes. Pharmacol Res 48: 127-132, 2003.
15. Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, and Epstein PN. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51: 174-181, 2002.
16. Norby FL, Aberle NS, Kajstura J, Anversa P, and Ren J. Transgenic overexpression of insulin-like growth factor I prevents streptozotocin-induced cardiac contractile dysfunction and beta-adrenergic response in ventricular myocytes. J Endocrinol 180: 175-182, 2004.
17. Obrenovich ME and Monnier VM. Vitamin B1 blocks damage caused by hyperglycemia. Sci Aging Knowledge Environ 2003: E6, 2003.
18. Perry CG and Petrie JR. Insulin-sensitising agents: beyond thiazolidinediones. Expert Opin Emerg Drugs 7: 165-174, 2002.
19. Ren J and Bode AM. Altered cardiac excitation-contraction coupling in ventricular myocytes from spontaneously diabetic BB rats. Am J Physiol Heart Circ Physiol 279: H238-H244, 2000.
20. Ren J and Ceylan-Isik AF. Diabetic cardiomyopathy: do women differ from men? Endocrine 25: 73-83, 2004.
21. Ren J and Davidoff AJ. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol Heart Circ Physiol 272: H148-H158, 1997.
22. Ren J, Roughead ZK, Wold LE, Norby FL, Rakoczy S, Mabey RL, and Brown-Borg HM. Increases in insulin-like growth factor-1 level and peroxidative damage after gestational ethanol exposure in rats. Pharmacol Res 47: 341-347, 2003.
23. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, and Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14: 1521-1528, 1994.
24. Shen X, Ye G, Metreveli NS, and Epstein PN. Cardiomyocyte defects in diabetic models and protection with cardiac-targeted transgenes. Methods Mol Med 112: 379-388, 2005.
25. Tobias SL, van der WJ, Davis RE, Icke GC, and Atkinson PM. Alcohol intakes and deficiencies in thiamine and vitamin B6 in black patients with cardiac failure. S Afr Med J 76: 299-302, 1989.
26. Vasan S, Zhang X, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, Cerami A, Egan J, and Ulrich P. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382: 275-278, 1996.
27. Wold LE, Ceylan-Isik AF, and Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin 26: 908-917, 2005.
28. Wold LE and Ren J. Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase-dependent oxidative stress mechanism. Biochem Biophys Res Commun 318: 1066-1071, 2004.
29. Ye G, Metreveli NS, Ren J, and Epstein PN. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52: 777-783, 2003.